Viewing Study NCT00996359


Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2026-01-16 @ 10:59 AM
Study NCT ID: NCT00996359
Status: TERMINATED
Last Update Posted: 2013-09-17
First Post: 2009-10-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation
Sponsor: University of Medicine and Dentistry of New Jersey
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
None Multiple Myeloma and Plasma Cell Neoplasm View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult acute myeloid leukemia with 11q23 (MLL) abnormalities View
None adult acute myeloid leukemia with inv(16)(p13;q22) View
None adult acute myeloid leukemia with t(15;17)(q22;q12) View
None adult acute myeloid leukemia with t(16;16)(p13;q22) View
None adult acute myeloid leukemia with t(8;21)(q22;q22) View
None recurrent adult acute myeloid leukemia View
None adult acute myeloid leukemia in remission View
None recurrent adult acute lymphoblastic leukemia View
None adult acute lymphoblastic leukemia in remission View
None relapsing chronic myelogenous leukemia View
None accelerated phase chronic myelogenous leukemia View
None chronic phase chronic myelogenous leukemia View
None blastic phase chronic myelogenous leukemia View
None refractory chronic lymphocytic leukemia View
None de novo myelodysplastic syndromes View
None previously treated myelodysplastic syndromes View
None secondary myelodysplastic syndromes View
None chronic myelomonocytic leukemia View
None recurrent adult diffuse large cell lymphoma View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent mantle cell lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent marginal zone lymphoma View
None recurrent small lymphocytic lymphoma View
None recurrent adult Burkitt lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent adult T-cell leukemia/lymphoma View
None recurrent cutaneous T-cell non-Hodgkin lymphoma View
None recurrent mycosis fungoides/Sezary syndrome View
None adult nasal type extranodal NK/T-cell lymphoma View
None peripheral T-cell lymphoma View
None hepatosplenic T-cell lymphoma View
None anaplastic large cell lymphoma View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None nodal marginal zone B-cell lymphoma View
None splenic marginal zone lymphoma View
None recurrent adult Hodgkin lymphoma View
None refractory multiple myeloma View
None childhood acute myeloid leukemia in remission View
None recurrent childhood acute myeloid leukemia View
None childhood acute lymphoblastic leukemia in remission View
None recurrent childhood acute lymphoblastic leukemia View
None childhood diffuse large cell lymphoma View
None recurrent childhood large cell lymphoma View
None Burkitt lymphoma View
None childhood immunoblastic large cell lymphoma View
None angioimmunoblastic T-cell lymphoma View
None recurrent childhood lymphoblastic lymphoma View
None recurrent childhood anaplastic large cell lymphoma View
None recurrent childhood grade III lymphomatoid granulomatosis View
None recurrent childhood small noncleaved cell lymphoma View
None childhood nasal type extranodal NK/T-cell lymphoma View